DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 020500
The generic ingredient in MEPRON is atovaquone. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the atovaquone profile page.
Summary for 020500
Tradename: | MEPRON |
Applicant: | Glaxosmithkline Llc |
Ingredient: | atovaquone |
Patents: | 0 |
Therapeutic Class: | Antiparasitics |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 020500
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MEPRON | atovaquone | SUSPENSION;ORAL | 020500 | NDA | GlaxoSmithKline LLC | 0173-0547 | N | 0173-0547-00 |
MEPRON | atovaquone | SUSPENSION;ORAL | 020500 | NDA | GlaxoSmithKline LLC | 0173-0665 | N | 0173-0665-18 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 750MG/5ML | ||||
Approval Date: | Feb 8, 1995 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 020500
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline Llc | MEPRON | atovaquone | SUSPENSION;ORAL | 020500-001 | Feb 8, 1995 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Glaxosmithkline Llc | MEPRON | atovaquone | SUSPENSION;ORAL | 020500-001 | Feb 8, 1995 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Glaxosmithkline Llc | MEPRON | atovaquone | SUSPENSION;ORAL | 020500-001 | Feb 8, 1995 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Complete Access Available with Subscription